Literature DB >> 23863801

Visit-to-visit blood pressure variability is related to albuminuria variability and progression in patients with type 2 diabetes.

S Noshad1, M Mousavizadeh, M Mozafari, M Nakhjavani, A Esteghamati.   

Abstract

Recent studies have suggested that visit-to-visit variability of blood pressure (BP) is correlated with microalbuminuria in patients with diabetes, independent of mean pressure. We investigated the contribution of BP variability to albuminuria progression in normoalbuminuric type 2 diabetes patients. BP and urinary albumin excretion of patients were assessed in each visit during a median follow-up of 31 months. Variability was assessed using standard deviation, coefficient of variation, standard deviation independent of mean, peak, average real variability, and average real variability independent of mean. Of 194 patients enrolled, 31 subjects (16.0%) developed microalbuminuria. Systolic blood pressure (SBP) variability indices (except for coefficient of variation and average real variability) were significant predictors of microalbuminuria in multivariate Cox regression models (hazard ratio ranging from 2.02 to 2.76). The same was not observed for diastolic blood pressure. Using linear regression, SBP variability significantly correlated with some but not all indices of albuminuria variability. Peak SBP was the strongest predictor of albuminuria variability in multivariate models (standardized beta ranging from 0.216 to 0.339). In conclusion, visit-to-visit variability of SBP is an independent risk factor for development of microalbuminuria in patients with diabetes, and is associated with an increased variability in albuminuria.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23863801     DOI: 10.1038/jhh.2013.36

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  45 in total

Review 1.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

2.  Calcium antagonist added to angiotensin receptor blocker: a recipe for reducing blood pressure variability?: evidence from day-by-day home blood pressure monitoring.

Authors:  Gianfranco Parati; Grzegorz Bilo
Journal:  Hypertension       Date:  2012-04-30       Impact factor: 10.190

3.  Stroke and blood-pressure variation: new permutations on an old theme.

Authors:  Bo Carlberg; Lars Hjalmar Lindholm
Journal:  Lancet       Date:  2010-03-13       Impact factor: 79.321

Review 4.  Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion.

Authors:  C E Mogensen; E Vestbo; P L Poulsen; C Christiansen; E M Damsgaard; H Eiskjaer; A Frøland; K W Hansen; S Nielsen; M M Pedersen
Journal:  Diabetes Care       Date:  1995-04       Impact factor: 19.112

Review 5.  Blood pressure variability, cardiovascular risk, and risk for renal disease progression.

Authors:  Gianfranco Parati; Juan E Ochoa; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease.

Authors:  Latika Sibal; Sharad C Agarwal; Philip D Home; Rainer H Boger
Journal:  Curr Cardiol Rev       Date:  2010-05

8.  Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke.

Authors:  S C Howard; P M Rothwell
Journal:  Cerebrovasc Dis       Date:  2009-07-24       Impact factor: 2.762

9.  Is there a physiological variability for albumin excretion rate? Study in patients with diabetes type 1 and non-diabetic individuals.

Authors:  M B Gomes; M F Gonçalves
Journal:  Clin Chim Acta       Date:  2001-02       Impact factor: 3.786

Review 10.  Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

Authors:  Juan P Casas; Weiliang Chua; Stavros Loukogeorgakis; Patrick Vallance; Liam Smeeth; Aroon D Hingorani; Raymond J MacAllister
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321

View more
  13 in total

Review 1.  Blood pressure variability: assessment, predictive value, and potential as a therapeutic target.

Authors:  Gianfranco Parati; Juan Eugenio Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

2.  Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke: A Secondary Analysis of PRoFESS.

Authors:  Adam de Havenon; Nora F Fino; Brian Johnson; Ka-Ho Wong; Jennifer J Majersik; David Tirschwell; Natalia Rost
Journal:  Stroke       Date:  2019-09-20       Impact factor: 7.914

3.  Effect of blood pressure trajectory and variability on new-onset chronic kidney disease in patients with type 2 diabetes.

Authors:  Cheng-Chieh Lin; Chia-Ing Li; Chiu-Shong Liu; Chih-Hsueh Lin; Mu-Cyun Wang; Shing-Yu Yang; Tsai-Chung Li
Journal:  Hypertens Res       Date:  2022-03-03       Impact factor: 3.872

4.  Visit-to-visit systolic blood pressure variability and microvascular complications among patients with diabetes.

Authors:  Min-Woong Sohn; Noam Epstein; Elbert S Huang; Zhiping Huo; Nicholas Emanuele; George Stukenborg; Marylou Guihan; Junping Li; Elly Budiman-Mak
Journal:  J Diabetes Complications       Date:  2016-09-14       Impact factor: 2.852

Review 5.  Clinical relevance of visit-to-visit blood pressure variability: impact on renal outcomes.

Authors:  G Parati; X Liu; J E Ochoa
Journal:  J Hum Hypertens       Date:  2013-10-17       Impact factor: 3.012

6.  Blood pressure variability: An emerging target for risk reduction in the setting of hypertensive emergency.

Authors:  Adam de Havenon
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-25       Impact factor: 3.738

7.  Long-Term Visit-to-Visit Blood Pressure Variability and Renal Function Decline in Patients With Hypertension Over 15 Years.

Authors:  Yook Chin Chia; Hooi Min Lim; Siew Mooi Ching
Journal:  J Am Heart Assoc       Date:  2016-11-07       Impact factor: 5.501

8.  An Observational Registry to Assess Urinary Albumin Evolution in Saudi Hypertensive Patients with the Current Treatment Local algorithm: Results of the RATIONAL Study.

Authors:  Mostafa Qaid Al Shamiri; Saeed M G Al-Ghamdi; Rafif M Farahat; Hosam Nasr El Desouki; Mohammed Saeed ElNazer; Hossam El Deen Moustafa Saleh; Ashraf Abdulghani Abo El Naga; Adil Mohammed Salih; Khedr Abdul Aal Mahmoud; Nasim Ahmad Ahmad
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-04-23

9.  Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.

Authors:  Claudia R L Cardoso; Nathalie C Leite; Gil F Salles
Journal:  Cardiovasc Diabetol       Date:  2020-05-02       Impact factor: 9.951

10.  Midlife Blood Pressure Variability and Risk of All-Cause Mortality and Cardiovascular Events During Extended Follow-up.

Authors:  Adam de Havenon; Alen Delic; Shadi Yaghi; Ka-Ho Wong; Jennifer J Majersik; Eric Stulberg; David Tirschwell; Mohammad Anadani
Journal:  Am J Hypertens       Date:  2021-12-01       Impact factor: 3.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.